ClinicalTrials.Veeva

Menu

Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product

Becton, Dickinson and Company (BD) logo

Becton, Dickinson and Company (BD)

Status

Enrolling

Conditions

Sepsis

Treatments

Diagnostic Test: control Aerobic/F Culture Vials
Diagnostic Test: test Aerobic/F Culture Vials

Study type

Observational

Funder types

Industry

Identifiers

NCT06426121
IDS-23CNBAC01

Details and patient eligibility

About

This study is a multi-center, randomized clinical validation. Subjects should be fully informed of this protocol and related risks, and can only be enrolled into this study after signing the informed consent form. Blood collection of the subjects at the same puncture point at a single site will be injected into the test vial and the control vial respectively, and the vials will be transferred to the BACTEC system for culture and the results will be observed. After the BACTEC system incubation completion, the vials will be subcultured. Strains grown on plates will be identified using appropriate methods and, if possible, at the species level.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject is willing to provide written informed consent to sponsor.

  • Blood specimens

  • Patients with suspected blood infection that have one or more of the following characteristics :

    a) Body temperature > 38°C or body temperature <36°C; b) chills; c) increased peripheral blood leukocyte count (count > 10.0×109/L, especially if there is a "left shift") or decrease (count < 3.0×109/L); d) Respiratory rate > 20 beats/min or arterial partial pressure of carbon dioxide (PaCO2) <32mmHg; e) Heart rate> 90 beats/min; f) mucocutaneous hemorrhage; g) coma; h) Multi-organ dysfunction; i) decreased blood pressure; j) Elevated inflammatory response parameters such as C-reactive protein or hypersensitive C-reactive protein, procalcitonin (PCT), 1,3-β-D-glucan (G test), etc.

Exclusion criteria

  • Subjects have been enrolled in this study and samples have been collected
  • Patients with severe and very severe anemia (last hemoglobin <60g/L within seven days)
  • Females with known pregnancy

Trial design

1,000 participants in 2 patient groups

BD BACTEC™ Plus Aerobic/F Culture Vials(test)
Description:
Additional blood sample collected compared to clinical routine care
Treatment:
Diagnostic Test: test Aerobic/F Culture Vials
BD BACTEC™ Plus Aerobic/F Culture Vials(control)
Description:
clinical routine care
Treatment:
Diagnostic Test: control Aerobic/F Culture Vials

Trial contacts and locations

1

Loading...

Central trial contact

namei hu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems